login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
IMMUNOPRECISE ANTIBODIES LTD (IPA) Stock News
NASDAQ:IPA -
CA45257F2008
-
Common Stock
2.07
USD
+0.14 (+7.25%)
Last: 9/3/2025, 8:24:29 PM
2.12
USD
+0.05 (+2.42%)
After Hours:
9/3/2025, 8:24:29 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
IPA Latest News, Press Relases and Analysis
All
Press Releases
7 days ago - By: Chartmill
- Mentions:
CYTK
MNKD
UTHR
IONS
...
There are notable gap-ups and gap-downs in today's session.
5 days ago - By: Zacks Investment Research
- Mentions:
PHR
Phreesia (PHR) Q2 Earnings and Revenues Beat Estimates
6 days ago - By: ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to “HYFT”
7 days ago - By: Benzinga
- Mentions:
CYTK
UTHR
CGC
ALTS
...
12 Health Care Stocks Moving In Tuesday's Intraday Session
7 days ago - By: ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies to Participate at H.C. Wainwright's 27th Annual Global Investment Conference in New York
13 days ago - By: ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Advances AI Discovered and Developed Universal Dengue Vaccine Initiative: Moves into Preclinical Antibody Generation
a month ago - By: ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd. Divests Netherlands Facilities to AVS Bio to Accelerate Bio-Native AI Innovation
a month ago - By: The Motley Fool
- Mentions:
AMD
ImmunoPrecise (IPA) Q4 2025 Earnings Transcript
a month ago - By: Zacks Investment Research
- Mentions:
DOCS
ImmunoPrecise Antibodies Ltd. (IPA) Reports Q4 Loss, Lags Revenue Estimates
a month ago - By: ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies (IPA) Reports Full Fiscal Year 2025 Results, Record Fourth Quarter Revenue, and Record Fourth Quarter Adjusted EBITDA
2 months ago - By: ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Releases New Findings Showing LENSai™ Quickly Flags Anti-Drug-Antibody Risk—Long Before the Clinic
2 months ago - By: ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Appoints Healthcare Data Visionary Jeff Fried to Advisory Board
2 months ago - By: ImmunoPrecise Antibodies Ltd.
IPA to Report Financial Results and Recent Business Highlights for Fourth Quarter and Full Fiscal Year 2025 on July 29, 2025
2 months ago - By: ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Regains Compliance with Nasdaq Minimum Bid Price Requirement
2 months ago - By: ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Appoints Industry Veteran Jon Lieber to Board of Directors
2 months ago - By: ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Validates LENSai Epitope Mapping Platform Across Broad Range of Unseen Therapeutic Targets Beyond Training Data
3 months ago - By: ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Advances Universal Dengue Vaccine, Confirming Safety, Immune Activation, and Structural Stability Using its LENSai™ Platform Powered by Patented HYFT® Technology
3 months ago - By: ImmunoPrecise Antibodies Ltd.
AI-Designed GLP-1 Peptides from ImmunoPrecise Antibodies Surpass Semaglutide in Receptor Activation Studies
3 months ago - By: ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Announces AI-Driven Breakthrough in Universal Dengue Vaccine Discovery
4 months ago - By: ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Engages CORE IR to Enhance Investor Engagement Efforts
4 months ago - By: ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies (IPA) to Present at Maxim Group’s 2025 Virtual Tech Conference
4 months ago - By: ImmunoPrecise Antibodies Ltd.
IPA’s LENSai™ Platform Delivers X-Ray–Level Epitope Mapping Insights in Hours, Matching Gold-Standard Methods with Greater Speed
5 months ago - By: ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Highlights Alignment of Proprietary AI-Driven Platform LENSai™ with FDA's Shift to Non-Animal Testing Methods
6 months ago - By: ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025
6 months ago - By: Zacks Investment Research
- Mentions:
PIII
P3 Health Partners Inc. (PIII) Reports Q4 Loss, Lags Revenue Estimates
6 months ago - By: Benzinga
A Look Ahead: ImmunoPrecise Antibodies's Earnings Forecast
Please enable JavaScript to continue using this application.